home / news releases


Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Now Trending

Company Name:Nano One Materials Corp
Stock Symbol:NNOMF
Market:OTC
Website:nanoone.ca

Menu

NNOMF NNOMF Quote NNOMF Short NNOMF News NNOMF Articles NNOMF Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

UG - Stellantis to Announce First Half 2024 Results on July 25

Stellantis to Announce First Half 2024 Results on July 25 AMSTERDAM, July 1, 2024 - Stellantis N.V. announced today that its First Half 2024 Results will be released on Thursday, July 25, 2024. A live webcast and conference call of the First Half 2024 Results will begin at 2:00 ...

VNDA - Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex PR Newswire WASHINGTON , July 1, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. District Court for the District of ...

EQIX - MEDIA ALERT: Equinix Sets Conference Call for Second-Quarter

MEDIA ALERT: Equinix Sets Conference Call for Second-Quarter PR Newswire REDWOOD CITY, Calif. , July 1, 2024 /PRNewswire/ -- Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company ® , today announced that it will hold its quarterly ...

ALRN - Aileron Therapeutics to be Included in the Russell Microcap® Index

Aileron Therapeutics to be Included in the Russell Microcap® Index PR Newswire AUSTIN, Texas , July 1, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron" or the "Company") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of...

OVID - Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic profile was achieved at the targeted clinical dose, supporting once daily d...

TELL - Tellurian Closes $260 Million Asset Sale and Retires Senior Secured Debt

Tellurian Inc. (Tellurian or the Company) (NYSE American: TELL) announced today that it has closed the previously reported sale of its integrated upstream assets for $260 million to affiliates of Aethon Energy Management LLC (Aethon), fulfilling a key objective outlined in May and substantially s...

PESI - Perma-Fix Environmental Services Added to Membership of Russell 3000 Index

ATLANTA, July 01, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) announces it has been added as a member of the Russell 3000 Index, effective after the US market opens today, July 1, as part of the 2024 Russell indexes reconstitution. ...

SLRC - SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended June 30, 2024

NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended June 30, 2024 on Wednesday, August 7, 2024 after the close of the financial markets. The Company wil...

LNDC - Lifecore Biomedical Announces Cooperation Agreement with 22NW

CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced it has reached a cooperation agreemen...

NDLS - Noodles & Company Celebrates National Mac & Cheese Day All Month Long with the Return of Macapalooza

Noodles & Company Celebrates National Mac & Cheese Day All Month Long with the Return of Macapalooza Noodles & Company Celebrates National Mac & Cheese Day All Month Long with the Return of Macapalooza PR Newswire This Month Only, Noodles Unveils New Limite...

Previous 10 Next 10